|
1
|
Lai KN, Leung JC, Chan LY, Saleem MA,
Mathieson PW, Lai FM and Tang SC: Activation of podocytes by
mesangial-derived TNF-alpha: Glomerulo-podocytic communication in
IgA nephropathy. Am J Physiol Renal Physiol. 294:F945–F955. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'Amico G and Bazzi C: Pathophysiology of
proteinuria. Kidney Int. 63:809–825. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang G, Zou B, Lv J, Li T, Huai G, Xiang
S, Lu S, Luo H, Zhang Y, Jin Y and Wang Y: Notoginsenoside R1
attenuates glucose-induced podocyte injury via the inhibition of
apoptosis and the activation of autophagy through the PI3K/Akt/mTOR
signaling pathway. Int J Mol Med. 39:559–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verzola D, Gandolfo MT, Ferrario F,
Rastaldi MP, Villaggio B, Gianiorio F, Giannoni M, Rimoldi L,
Lauria F, Miji M, et al: Apoptosis in the kidneys of patients with
type II diabetic nephropathy. Kidney Int. 72:1262–1272. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
White KE, Bilous RW, Marshall SM, El Nahas
M, Remuzzi G, Piras G, De Cosmo S and Viberti G: Podocyte number in
normotensive type 1 diabetic patients with albuminuria. Diabetes.
51:3083–3089. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang H, Wang Q and Li S: MicroRNA-218
promotes high glucose-induced apoptosis in podocytes by targeting
heme oxygenase-1. Biochem Biophys Res Commun. 471:582–588. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dai H, Zhang Y, Yuan L, Wu J, Ma L and Shi
H: CTGF mediates high-glucose induced epithelial-mesenchymal
transition through activation of β-catenin in podocytes. Ren Fail.
38:1711–1716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin Y, Liu S, Ma Q, Xiao D and Chen L:
Berberine enhances the AMPK activation and autophagy and mitigates
high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol.
794:106–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma L, Han C, Peng T, Li N, Zhang B, Zhen X
and Yang X: Ang-(1–7) inhibited mitochondrial fission in
high-glucose-induced podocytes by upregulation of miR-30a and
downregulation of Drp1 and p53. J Chin Med Assoc. 79:597–604. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao F, Yu J, Liu B, Guo Y, Li K, Deng J,
Zhang J, Wang C, Chen S, Du Y, et al: A novel function of microRNA
130a-3p in hepatic insulin sensitivity and liver steatosis.
Diabetes. 63:2631–2642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ofori JK, Salunkhe VA, Bagge A, Vishnu N,
Nagao M, Mulder H, Wollheim CB, Eliasson L and Esguerra JL:
Elevated miR-130a/miR130b/miR-152 expression reduces intracellular
ATP levels in the pancreatic beta cell. Sci Rep. 7:449862017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samandari N, Mirza AH, Nielsen LB, Kaur S,
Hougaard P, Fredheim S, Mortensen HB and Pociot F: Circulating
microRNA levels predict residual beta cell function and glycaemic
control in children with type 1 diabetes mellitus. Diabetologia.
60:354–363. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Panguluri SK, Tur J, Chapalamadugu KC,
Katnik C, Cuevas J and Tipparaju SM: MicroRNA-301a mediated
regulation of Kv4.2 in diabetes: Identification of key modulators.
PLoS One. 8:e605452013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Z, Wan J, Hou X, Geng J, Li X and Bai
X: MicroRNA-27a promotes podocyte injury via PPARγ-mediated
β-catenin activation in diabetic nephropathy. Cell Death Dis.
8:e26582017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Song S and Luo H: Regulation of
podocyte lesions in diabetic nephropathy via miR-34a in the Notch
signaling pathway. Medicine. 95:e50502016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen YQ, Wang XX, Yao XM, Zhang DL, Yang
XF, Tian SF and Wang NS: MicroRNA-195 promotes apoptosis in mouse
podocytes via enhanced caspase activity driven by BCL2
insufficiency. Am J Nephrol. 34:549–559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Li ZP, Zhang RQ and Zhang HM:
Repression of miR-217 protects against high glucose-induced
podocyte injury and insulin resistance by restoring PTEN-mediated
autophagy pathway. Biochem Biophys Res Commun. 483:318–324. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CL, Lee PH, Hsu YC, Ko JY, Chuang PC,
Huang YT, Wang SY, Wu SL, Chen YS, Chiang WC, et al: MicroRNA-29a
promotion of nephrin acetylation ameliorates hyperglycemia-induced
podocyte dysfunction. J Am Soc Nephrol. 25:1698–1709. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hosako H, Martin GS, Barrier M, Chen YA,
Ivanov IV and Mirkes PE: Gene and microRNA expression in
p53-deficient day 8.5 mouse embryos. Birth Defects Res A Clin Mol
Teratol. 85:546–555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esguerra JL, Bolmeson C, Cilio CM and
Eliasson L: Differential glucose-regulation of microRNAs in
pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki
rat. PLoS One. 6:e186132011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun LN, Liu XC, Chen XJ, Guan GJ and Liu
G: Curcumin attenuates high glucose-induced podocyte apoptosis by
regulating functional connections between caveolin-1
phosphorylation and ROS. Acta Pharmacol Sin. 37:645–655. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun WH, Liu F, Chen Y and Zhu YC: Hydrogen
sulfide decreases the levels of ROS by inhibiting mitochondrial
complex IV and increasing SOD activities in cardiomyocytes under
ischemia/reperfusion. Biochem Biophys Res Commun. 421:164–169.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rahman MM, Muse AY, Khan DMIO, Ahmed IH,
Subhan N, Reza HM, Alam MA, Nahar L and Sarker SD: Apocynin
prevented inflammation and oxidative stress in carbon tetra
chloride induced hepatic dysfunction in rats. Biomed Pharmacother.
92:421–428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Du J, Niu X, Fu N, Wang R, Zhang
Y, Zhao S, Sun D and Nan Y: MiR-130a-3p attenuates activation and
induces apoptosis of hepatic stellate cells in nonalcoholic
fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Cell Death Dis. 8:e27922017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu Y, Gao W, Zhang C, Wen S, Huangfu H,
Kang J and Wang B: Hsa-miR-301a-3p acts as an oncogene in laryngeal
squamous cell carcinoma via target regulation of Smad4. J Cancer.
6:1260–1275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia X, Zhang K, Cen G, Jiang T, Cao J,
Huang K, Huang C, Zhao Q and Qiu Z: MicroRNA-301a-3p promotes
pancreatic cancer progression via negative regulation of SMAD4.
Oncotarget. 6:21046–21063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
West NR, Hegazy AN, Owens BMJ, Bullers SJ,
Linggi B, Buonocore S, Coccia M, Görtz D, This S, Stockenhuber K,
et al: Oncostatin M drives intestinal inflammation and predicts
response to tumor necrosis factor-neutralizing therapy in patients
with inflammatory bowel disease. Nat Med. 23:579–589. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pampfer S, Cordi S, Dutrieux C,
Vanderheyden I, Marchand C and De Hertogh R: Interleukin 1beta
mediates the effect of high D-glucose on the secretion of TNF-alpha
by mouse uterine epithelial cells. Cytokine. 11:500–509. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reddy AB, Ramana KV, Srivastava S,
Bhatnagar A and Srivastava SK: Aldose reductase regulates high
glucose-induced ectodomain shedding of tumor necrosis factor
(TNF)-alpha via protein kinase C-delta and TNF-alpha converting
enzyme in vascular smooth muscle cells. Endocrinology. 150:63–74.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzalez Y, Herrera MT, Soldevila G,
Garcia-Garcia L, Fabián G, Pérez-Armendariz EM, Bobadilla K,
Guzmán-Beltrán S, Sada E and Torres M: High glucose concentrations
induce TNF-α production through the down-regulation of CD33 in
primary human monocytes. BMC Immunol. 13:192012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bruggeman LA, Drawz PE, Kahoud N, Lin K,
Barisoni L and Nelson PJ: TNFR2 interposes the proliferative and
NF-κB-mediated inflammatory response by podocytes to TNF-α. Lab
Invest. 91:413–425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khan SB, Cook HT, Bhangal G, Smith J, Tam
FW and Pusey CD: Antibody blockade of TNF-alpha reduces
inflammation and scarring in experimental crescentic
glomerulonephritis. Kidney Int. 67:1812–1820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Basturk T, Unsal A, Ulas T, Koc Y, Sakaci
T, Ahbap E and Borlu F: Effects of rosiglitazone treatment on
insulin resistance and TNF-alpha levels in patients with chronic
kidney disease: A prospective study. Eur Rev Med Pharmacol Sci.
16:1519–1524. 2012.PubMed/NCBI
|
|
36
|
Camici M, Carpi A, Cini G, Galetta F and
Abraham N: Podocyte dysfunction in aging-related
glomerulosclerosis. Front Biosci (Schol Ed). 3:995–1006. 2011.
View Article : Google Scholar : PubMed/NCBI
|
